Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe and the United States of America (USA). The aim of this
trial is to compare the use of Insulin Detemir once a day (morning or evening) to NPH Insulin
once a day (evening) when added to treatment with oral antidiabetic drugs in patients with
Type 2 diabetes.